Despite contemporary management, patients with acute coronary syndrome (ACS) remain at risk of recurrent adverse cardiovascular events.
Marco Roffi , MD, is Director of the Interventional Cardiology Unit at the University Hospital of Geneva Switzerland.
Advertisement
Articles by Marco Roffi , MD, is Director of the Interventional Cardiology Unit at the University Hospital of Geneva Switzerland.
Advertisement
Latest Updated Articles
- Stopping clopidogrel after ACS: Impact on incidence of death and MI
October 21st 2008
Advertisement
Advertisement
Trending on HCPLive
1
Long-Acting Growth Hormone Analogs: Beyond Convenience to Individualized Care
2
How Jahi McMath's Case Exposed the Limits of Brain Death
3
Tips for Safe Management of Skin Disease During Pregnancy, With Jenny Murase, MD
4
Increasing Guideline-Directed Care Adherence in Peripheral Artery Disease
5